TY - JOUR
T1 - Prenatal diagnosis: Array comparative genomic hybridization in fetuses with abnormal sonographic findings
AU - Vestergaard, Else Marie
AU - Christensen, Rikke
AU - Petersen, Olav Bjørn
AU - Vogel, Ida
N1 - This article is protected by copyright. All rights reserved.
PY - 2013/4/16
Y1 - 2013/4/16
N2 - OBJECTIVE: To evaluate the clinical value of a high resolution whole-genome array method for examination of genomic imbalances in prenatal samples (46 amniotic fluid, 17 chorionic villus, and 26 products of conception) from fetuses with abnormal ultrasound, in a clinical setting where more than 90% of pregnant women receive 1(st) trimester combined screening and a 2(nd) trimester anomaly scan. DESIGN: Cross-sectional study. SETTING: Fetal medicine units (national health care system) in Central and North Denmark Regions from March 2009 to April 2012. SAMPLES: Eighty-nine samples obtained at gestational weeks 11.5 - 35.0 (mean 19.3), either during ongoing pregnancy or after termination. METHODS: DNA was extracted directly from amniotic fluid cells and chorionic villus samples, or from cultured cells, and examined with 80 kb resolution oligonucleotide array-based comparative genomic hybridisation (aCGH). MAIN OUTCOME MEASURES: Clinically significant copy number variations identified by aCGH. RESULTS: We detected clinically significant copy number variations in eleven fetuses (12%, confidence interval 6.0-19%) with structural malformations. Three cases (3.4%) had uncertain clinical significant variations and incidental findings. CONCLUSIONS: ACGH is a valuable diagnostic tool when fetal malformations are detected. More affected fetuses may be diagnosed at an earlier gestational age providing better possibilities for postnatal treatment and allowing for women to decide earlier on termination of pregnancy. In cases where a normal result has reduced the risk of significant chromosomal aberration aCGH may facilitate parental decision-making on whether to continue the pregnancy. This article is protected by copyright. All rights reserved.
AB - OBJECTIVE: To evaluate the clinical value of a high resolution whole-genome array method for examination of genomic imbalances in prenatal samples (46 amniotic fluid, 17 chorionic villus, and 26 products of conception) from fetuses with abnormal ultrasound, in a clinical setting where more than 90% of pregnant women receive 1(st) trimester combined screening and a 2(nd) trimester anomaly scan. DESIGN: Cross-sectional study. SETTING: Fetal medicine units (national health care system) in Central and North Denmark Regions from March 2009 to April 2012. SAMPLES: Eighty-nine samples obtained at gestational weeks 11.5 - 35.0 (mean 19.3), either during ongoing pregnancy or after termination. METHODS: DNA was extracted directly from amniotic fluid cells and chorionic villus samples, or from cultured cells, and examined with 80 kb resolution oligonucleotide array-based comparative genomic hybridisation (aCGH). MAIN OUTCOME MEASURES: Clinically significant copy number variations identified by aCGH. RESULTS: We detected clinically significant copy number variations in eleven fetuses (12%, confidence interval 6.0-19%) with structural malformations. Three cases (3.4%) had uncertain clinical significant variations and incidental findings. CONCLUSIONS: ACGH is a valuable diagnostic tool when fetal malformations are detected. More affected fetuses may be diagnosed at an earlier gestational age providing better possibilities for postnatal treatment and allowing for women to decide earlier on termination of pregnancy. In cases where a normal result has reduced the risk of significant chromosomal aberration aCGH may facilitate parental decision-making on whether to continue the pregnancy. This article is protected by copyright. All rights reserved.
U2 - 10.1111/aogs.12146
DO - 10.1111/aogs.12146
M3 - Journal article
C2 - 23590624
SN - 0001-6349
VL - 92
SP - 762
EP - 768
JO - Acta Obstetricia et Gynecologica Scandinavica
JF - Acta Obstetricia et Gynecologica Scandinavica
IS - 7
ER -